VistaGen Therapeutics Inc. (VTGN)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary 
XMEX $
0. 20
-0.01
-4.7619%
$
10.48M Market Cap
- P/E Ratio
- Div Yield
558,500 Volume
-1.6 Eps
$ 0.21
Previous Close Want to track VTGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
VistaGen Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Dinan Hu R Squared Ltd | 27,745 | $21,086.2 | $5,615.59 | -$15,470.61 | -73.37% |
 Kathleen Thornhill Confluence Wealth Services Inc. | 32,610 | $24,783.6 | $6,597 | -$18,186.6 | -73.38% |
 Kevin Roan Stempoint Capita LLP | 616,749 | $1.8M | $128,468.82 | -$1.67M | -92.88% |
 Christopher C. Powers Farther Finance Advisors, LLC | 15,000 | $11,400 | $3,150 | -$8,250 | -72.37% |
 Douglas E. Morisoli Fairman Group, LLC | 29 | $149 | $5.97 | -$143.03 | -95.99% |
2026 © Marketlog. All Rights Reserved.
